COVID-19

November 11, 2021

VUMC tests drugs for COVID outpatient treatment

By Paul Govern
November 10, 2021

COVID test accuracy appears to vary by time of day

Vanderbilt researchers are examining the effect of time of day on COVID test accuracy.

By Paul Govern
November 9, 2021

Study finds higher deaths among veterans in 2020, but less than general population

By Jake Lowary
Jeff Balser, MD, PhD, spoke of the importance of VUMC’s workforce in this week’s Leadership Assembly video presentation.
November 4, 2021

Leadership Assembly takeaways: Speaking up makes a difference

The importance of supporting Vanderbilt University Medical Center’s workforce is highlighted in this quarter’s Leadership Assembly theme, “Speaking Up, Lifting Up,” which is focused on strategies to amplify well-being.

By Holly Fletcher
November 3, 2021

COVID testing recommended for flu-like symptoms

Vanderbilt physicians recommend COVID testing for people who think they may have the flu because the symptoms for both infections overlap.

By Paul Govern
Seth Zost, PhD, has been honored for his research on COVID-19 and other life-threatening viral diseases.
October 28, 2021

Zost honored for research on COVID-19, other life-threatening viral diseases

Vanderbilt’s Seth Zost, PhD, has been awarded a major international prize for his research on COVID-19 and other life-threatening viral diseases. 

By Bill Snyder
October 21, 2021

Study explores impact of COVID-19 on children

By Jessica Pasley
October 20, 2021

Caring for caregivers

More than 1,000 bags given out Tuesday as part of the Caregivers Need Care Too initiative.
By VUMC News and Communications
October 7, 2021

Boosta-Palooza

VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week's Boosta-Palooza event.
By VUMC News and Communications
October 6, 2021

Pediatricians seeing increase in children with MIS-C after latest COVID surge

By Jessica Pasley
October 5, 2021

AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC

Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.
By Bill Snyder
October 1, 2021

VUMC research contributed to first COVID-19 pill now under review

Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.
By Bill Snyder
September 30, 2021

The COVID Mass Vaccination Site Team faced a daunting task – put 200,000 shots in arms in six months. The team never wavered.

The accomplishment earned the group the Elevate Team Award.
By Matt Batcheldor